Cystic Fibrosis Research

Research in cystic fibrosis (CF) investigates the underlying molecular mechanisms of the disease, focusing on the genetic mutations that cause it and the resulting protein defects. Studies examine how these defects impact cellular function, particularly in the lungs, pancreas, and digestive system. Investigations employ techniques in molecular biology, genetics, and cell biology to identify therapeutic targets. This includes exploring gene editing strategies, such as CRISPR, to correct genetic defects and developing novel drug therapies to manage symptoms and improve lung function. Research also addresses the complex interplay of diet and metabolism in CF patients and evaluates the efficacy and toxicity of pharmacological interventions.

Given Arkansas's demographic profile and the prevalence of certain genetic conditions, research in cystic fibrosis holds significant public health relevance for the state. Understanding health disparities and improving patient outcomes are key objectives, aiming to enhance the quality of life for individuals with CF in Arkansas. This work contributes to the state's growing biomedical research sector and supports efforts to address the needs of rare disease communities within the region.

This area of study draws upon expertise in child and adolescent health, genomics, and rare diseases. Collaborations extend to molecular biology techniques and applications, pharmacological effects and toxicity studies, and the analysis of health outcomes. The research engages faculty across institutions, fostering a multidisciplinary approach to understanding and treating cystic fibrosis.